ERBB2 and breast neoplasm: More recently, it has become apparent that the AR pathway is associated with breast tumor carcinogenesis, with differing mechanisms dependent on co-expression of HR or HER2 amplification [1,2] Although our understanding is still early, this signaling pathway has important prognostic and therapeutic implications.